David W Meline
CIK 1444612 · View on SEC EDGAR ↗
First SEC filing: Jan. 12, 2012 · Latest: Feb. 4, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 6, 2024 | PACB | P | 40,000 | $4.40 | $176,000 | 40,000 Direct | — | Acquired | -70.6% (price as of 2026-08-20) |
| Aug. 10, 2022 | MRNA | S | 164 | $173.66 | $28,480 | 2,857 Direct | -5.43% | Disposed | -17.5% (price as of 2026-08-20) |
| May 10, 2022 | MRNA | S | 156 | $133.71 | $20,859 | 2,583 Direct | -5.70% | Disposed | 7.1% (price as of 2026-08-20) |
| Feb. 10, 2022 | MRNA | S | 619 | $158.89 | $98,353 | 2,391 Direct | -20.56% | Disposed | -9.9% (price as of 2026-08-20) |
| Nov. 25, 2019 | AMGN | S | 8,737 | $234.36 | $2,047,603 | 49,378 Direct | -15.03% | Disposed | 86.1% (price as of 2026-08-20) |
| Oct. 29, 2013 | MMM | S | 2,835 | $125.08 | $354,602 | 0 Indirect | -100.00% | Disposed | 72.5% (price as of 2026-08-20) |
| Oct. 26, 2012 | MMM | S | 12,482 | $87.80 | $1,095,920 | 10,720 Direct | -53.80% | Disposed | 145.7% (price as of 2026-08-20) |
| Oct. 26, 2012 | MMM | S | 506 | $87.81 | $44,432 | 10,214 Direct | -4.72% | Disposed | 145.7% (price as of 2026-08-20) |
| July 29, 2011 | MMM | S | 2,300 | $86.92 | $199,916 | 0 Direct | -100.00% | Disposed | 148.2% (price as of 2026-08-20) |
| July 29, 2011 | MMM | S | 1,200 | $86.91 | $104,292 | 2,300 Direct | -34.29% | Disposed | 148.2% (price as of 2026-08-20) |
| July 29, 2011 | MMM | S | 1,982 | $86.90 | $172,236 | 3,500 Direct | -36.15% | Disposed | 148.2% (price as of 2026-08-20) |
Showing latest 100 of 113 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 14, 2025 | HPQ | Restricted Stock Units | Common Stock (9,568) | — | — | 9,568 | Acquired |
| June 18, 2024 | PACB | Stock Option (right to buy) | Common Stock (24,134) | $1.65 | June 18, 2034 | 24,134 | Acquired |
| Oct. 13, 2023 | PACB | Stock Option (right to buy) | Common Stock (86,954) | $7.98 | Oct. 13, 2033 | 86,954 | Acquired |
| Aug. 9, 2022 | MRNA | Restricted Stock Units | Common Stock (348) | $0.00 | — | 348 | Disposed |
| May 9, 2022 | MRNA | Restricted Stock Units | Common Stock (348) | $0.00 | — | 348 | Disposed |
| March 1, 2022 | MRNA | Restricted Stock Units | Common Stock (6,415) | $0.00 | — | 6,415 | Acquired |
| March 1, 2022 | MRNA | Stock Option (Right to Buy) | Common Stock (26,020) | $149.52 | March 1, 2032 | 26,020 | Acquired |
| Feb. 9, 2022 | MRNA | Restricted Stock Units | Common Stock (1,392) | $0.00 | — | 1,392 | Disposed |
| Feb. 9, 2021 | MRNA | Restricted Stock Units | Common Stock (5,570) | $0.00 | — | 5,570 | Acquired |
| Feb. 9, 2021 | MRNA | Stock Option (Right to Buy) | Common Stock (25,618) | $179.52 | Feb. 9, 2031 | 25,618 | Acquired |
| July 6, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock (271,303) | $59.15 | July 6, 2030 | 271,303 | Acquired |
| May 3, 2019 | AMGN | Nqso (Right to Buy) | Common Stock (39,382) | $177.31 | May 3, 2029 | 39,382 | Acquired |
| April 27, 2018 | AMGN | Nqso (Right to Buy) | Common Stock (34,702) | $177.46 | April 27, 2028 | 34,702 | Acquired |
| May 1, 2017 | AMGN | Nqso (Right to Buy) | Common Stock (38,126) | $162.60 | May 1, 2027 | 38,126 | Acquired |
| May 3, 2016 | AMGN | Nqso (Right to Buy) | Common Stock (38,112) | $156.35 | May 3, 2026 | 38,112 | Acquired |
| Feb. 4, 2014 | MMM | Non-qualified Stock Option (Right to Buy) [F2] | Common Stock (70,345) | $126.72 | Feb. 2, 2024 | 70,345 | Acquired |
| Jan. 2, 2014 | MMM | Restricted Stock Units | Common Stock (1,047) | — | — | 1,047 | Disposed |
| Dec. 3, 2013 | MMM | Restricted Stock Units | Common Stock (48) | — | — | 48 | Disposed |
| Aug. 30, 2013 | MMM | Restricted Stock Units | Common Stock (6,173) | — | — | 6,173 | Disposed |
| Feb. 8, 2013 | MMM | Restricted Stock Units | Common Stock (847) | — | — | 847 | Disposed |
| Feb. 5, 2013 | MMM | Non-qualified Stock Option (Right to Buy) [F3] | Common Stock (98,185) | $101.49 | Feb. 3, 2023 | 98,185 | Acquired |
| Oct. 26, 2012 | MMM | Non-qualified Stock Option (Right to Buy) | Common Stock (16,636) | $54.11 | Feb. 8, 2019 | 16,636 | Disposed |
| Feb. 9, 2012 | MMM | Restricted Stock Units | Common Stock (3,835) | — | — | 3,835 | Disposed |
| Feb. 9, 2012 | MMM | Restricted Stock Units | Common Stock (847) | — | — | 847 | Disposed |
| Feb. 9, 2012 | MMM | Restricted Stock Units | Common Stock (4,159) | — | — | 4,159 | Disposed |
| Feb. 7, 2012 | MMM | Non-qualified Stock Option (Right to Buy) [F1] | Common Stock (56,570) | $87.89 | Feb. 7, 2022 | 56,570 | Acquired |
| Sept. 2, 2011 | MMM | Restricted Stock Units | Common Stock (3,126) | — | — | 3,126 | Disposed |
| April 1, 2011 | MMM | Restricted Stock Units | Common Stock (3,835) | — | — | 3,835 | Acquired |
| March 15, 2011 | MMM | Restricted Stock Units | Common Stock (1,095) | — | — | 1,095 | Acquired |
| Feb. 9, 2011 | MMM | Restricted Stock Units | Common Stock (847) | — | — | 847 | Disposed |
| Feb. 8, 2011 | MMM | Non-qualified Stock Option (Right to Buy) [F1] | Common Stock (11,538) | $89.47 | Feb. 8, 2021 | 11,538 | Acquired |
| Sept. 2, 2010 | MMM | Restricted Stock Units | Common Stock (3,126) | — | — | 3,126 | Disposed |
| Sept. 1, 2010 | MMM | Restricted Stock Units | Common Stock (6,173) | — | — | 6,173 | Acquired |
| Feb. 9, 2010 | MMM | Non-qualified Stock Option (Right to Buy) | Common Stock (16,065) | $78.72 | Feb. 7, 2020 | 16,065 | Acquired |
| Feb. 9, 2010 | MMM | Restricted Stock Units | Common Stock (2,541) | — | — | 2,541 | Acquired |
| Feb. 9, 2009 | MMM | Non-qualified Stock Option (Right to Buy) | Common Stock (16,636) | $54.11 | Feb. 8, 2019 | 16,636 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 10 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Feb. 4, 2026 | EIKN | Stock Option (Right to Buy)→ Common Stock (67,043) | 67,043 | Direct |
| May 12, 2022 | MRNA | Common Stock | 2,583 | Direct |
| May 12, 2022 | MRNA | Stock Option (Right to Buy)→ Common Stock (26,020) | 26,020 | Direct |
| May 12, 2022 | MRNA | Restricted Stock Units→ Common Stock (6,415) | 6,415 | Direct |
| May 12, 2022 | MRNA | Restricted Stock Units→ Common Stock (3,830) | 3,830 | Direct |
| May 12, 2022 | MRNA | Stock Option (Right to Buy)→ Common Stock (25,618) | 25,618 | Direct |
| May 12, 2022 | MRNA | Stock Option (Right to Buy)→ Common Stock (271,303) | 271,303 | Direct |
| June 9, 2020 | MRNA | Common Stock | 1,500 | Direct |
| Sept. 8, 2008 | MMM | Common Stock | 9,379 | Direct |
| Sept. 8, 2008 | MMM | Non-qualified Stock Option (Right to Buy)→ Common Stock | — | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $385,222 | $0 | $1,409,049 | $1,382,983 | $464,667 | $569,966 | $70,833 | $4,282,720 |
| 2013 | $721,695 | $0 | $1,361,089 | $1,321,570 | $855,548 | $283,083 | $97,711 | $4,640,696 |
| 2012 | $657,107 | $0 | $1,278,001 | $845,156 | $786,146 | $253,079 | $79,520 | $3,899,009 |
AMGN
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | — | — | — | — | — | — | — | — |
| 2018 | — | — | — | — | — | — | — | — |
| 2017 | — | — | — | — | — | — | — | — |
MRNA
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $426,497 | $428,055 | — | — | — | — | $76,718 | $4,768,145 |
| 2021 | $616,962 | — | $2,000,000 | $2,000,000 | $560,000 | — | $59,312 | $5,236,274 |
| 2020 | $334,616 | $339,344 | — | $8,600,000 | — | — | — | $9,273,960 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.